市場調査レポート

商品コード

1741520

レッドバイオテクノロジー市場：製品タイプ別、用途別、エンドユーザー別、地域別

Red Biotechnology Market, By Product Type, By Application, By End User, By Geography

出版日: 2025年03月27日
発行: Coherent Market Insights
ページ情報: 英文 150 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 658,620円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,024,520円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,463,600円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.36円

全表示
概要
目次

概要

サンプル依頼リストに入れる

レッドバイオテクノロジー市場は、2025年には9,102億6,000万米ドルと推定され、2032年には1兆8,543億8,000万米ドルに達すると予測され、2025年から2032年までのCAGRは10.7%で推移すると予測されています。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	9,102億6,000万米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年 CAGR：	10.70%	2032年の価値予測	1兆8,543億8,000万米ドル

メディカルバイオテクノロジーとしても知られるレッドバイオテクノロジーは、医療・ヘルスケア用途に特化したバイオテクノロジーのサブセクターです。病気の治療や予防のための新薬、治療法、医療技術の開発にバイオテクノロジー技術を利用します。

市場力学：

レッドバイオテクノロジー市場は、いくつかの要因によって牽引されています。これらには、高齢化、慢性疾患の増加、パンデミックによる世界のヘルスケアニーズの増大が含まれます。ゲノミクス、個別化医療、遺伝子治療の進歩も主要な促進要因です。さらに、政府投資、規制当局の支援、民間セクターの関心の高まりも、革新的な治療法や治療法の開発を目指すレッドバイオテクノロジーの成長に寄与しています。

しかし、生物製剤の医薬品開発に関連する高コストが市場成長を抑制すると予想されています。

本調査の主な特徴

この調査レポートは、世界のレッドバイオテクノロジー市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模および複合年間成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。
また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界のレッドバイオテクノロジー市場の主要企業をプロファイルしています。
このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
世界のレッドバイオテクノロジー市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界のレッドバイオテクノロジー市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

Amgen Inc.
Gilead Sciences, Inc.
Biogen
Pfizer Inc.
Novartis AG
Hoffmann-La Roche
Johnson & Johnson Services, Inc.
Sanofi
Merck & Co. Inc.
AbbVie Inc.
GSK plc.
AstraZeneca
Eli Lilly and Company
Novo Nordisk A/S
Bayer AG
Bristol-Myers Squibb Company
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Boehringer Ingelheim International GmbH
Astellas Pharma Inc.

第10章セクション

調査手法
出版社について

Product Code: CMI6416

Red Biotechnology Market is estimated to be valued at USD 910.26 Bn in 2025 and is expected to reach USD 1,854.38 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 910.26 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.70%	2032 Value Projection:	USD 1,854.38 Bn

Red biotechnology, also known as medical biotechnology, is a subsector of biotechnology that focuses on medical and healthcare applications. It involves the use of biotechnology techniques to develop new drugs, therapies, and medical technologies for the treatment and prevention of diseases.

Market Dynamics:

Red biotechnology market is driven by several factors. These include the increasing global healthcare needs due to aging populations, rising chronic diseases, and pandemics. Advances in genomics, personalized medicine, and gene therapies are also key drivers. Additionally, government investments, regulatory support, and growing private sector interest contribute to the growth of red biotechnology, which aims to develop innovative medical treatments and therapies.

However, high costs associated with biologics drug development is expected to restrain the market growth.

Key features of the study:

This report provides in-depth analysis of the global red biotechnology market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global red biotechnology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Amgen, Gilead Sciences, Biogen, Pfizer, Novartis, Roche, Johnson & Johnson, Sanofi, Merck & Co., AbbVie, GlaxoSmithKline, AstraZeneca, Eli Lilly, Novo Nordisk, Bayer, Bristol-Myers Squibb, Teva Pharmaceutical, Takeda Pharmaceutical, Boehringer Ingelheim, and Astellas Pharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global red biotechnology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global red biotechnology market

Red Biotechnology Market Detailed Segmentation:

By Product Type
- Biopharmaceuticals
- Biosimilars
- Gene Therapy
- Tissue Engineering
- Cell Therapy
By Application
- Drug Discovery & Development
- Animal Biotechnology
- Environmental Biotechnology
- Medical Biotechnology
- Industrial Biotechnology
- Agricultural Biotechnology
- Others
By End User
- Pharmaceutical & Biopharmaceutical Companies
- Research Institutes
- Biotechnology Industry
- Hospitals & Diagnostic Centers
- Academic Institutions
Company Profiles
- Amgen
- Gilead Sciences
- Biogen
- Pfizer
- Novartis
- Roche
- Johnson & Johnson
- Sanofi
- Merck & Co.
- AbbVie
- GlaxoSmithKline
- AstraZeneca
- Eli Lilly
- Novo Nordisk
- Bayer
- Bristol-Myers Squibb
- Teva Pharmaceutical
- Takeda Pharmaceutical
- Boehringer Ingelheim
- Astellas Pharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet , By End User
- Market Snippet , By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing prevalence of chronic diseases
- Pricing pressures on biologics
- Biotech applications in agriculture
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Red Biotechnology Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Red Biotechnology Market, By Product Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Biosimilars
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Tissue Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Red Biotechnology Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drug Discovery & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Animal Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Environmental Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Medical Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Industrial Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Agricultural Biotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Red Biotechnology Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceutical & Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Biotechnology Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Hospitals & Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Academic Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Red Biotechnology Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biogen
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hoffmann-La Roche
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck & Co. Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

レッドバイオテクノロジー市場：製品タイプ別、用途別、エンドユーザー別、地域別

Red Biotechnology Market, By Product Type, By Application, By End User, By Geography

市場力学：

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界のレッドバイオテクノロジー市場- コロナウイルス（COVID-19）パンデミックの影響

第5章世界のレッドバイオテクノロジー市場、製品タイプ別、2020-2032年

第6章世界のレッドバイオテクノロジー市場、用途別、2020-2032年

第7章世界のレッドバイオテクノロジー市場、エンドユーザー別、2020-2032年

第8章世界のレッドバイオテクノロジー市場、地域別、2020年～2032年

第9章競合情勢

第10章セクション

Market Dynamics:

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Red Biotechnology Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Red Biotechnology Market, By Product Type, 2020-2032, (US$ Bn)

6. Global Red Biotechnology Market, By Application, 2020-2032, (US$ Bn)

7. Global Red Biotechnology Market, By End User, 2020-2032, (US$ Bn)

8. Global Red Biotechnology Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

レッドバイオテクノロジー市場：製品タイプ別、用途別、エンドユーザー別、地域別

Red Biotechnology Market, By Product Type, By Application, By End User, By Geography

市場力学：

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界のレッドバイオテクノロジー市場- コロナウイルス（COVID-19）パンデミックの影響

第5章 世界のレッドバイオテクノロジー市場、製品タイプ別、2020-2032年

第6章 世界のレッドバイオテクノロジー市場、用途別、2020-2032年

第7章 世界のレッドバイオテクノロジー市場、エンドユーザー別、2020-2032年

第8章 世界のレッドバイオテクノロジー市場、地域別、2020年～2032年

第9章 競合情勢

第10章 セクション

Market Dynamics:

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Red Biotechnology Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Red Biotechnology Market, By Product Type, 2020-2032, (US$ Bn)

6. Global Red Biotechnology Market, By Application, 2020-2032, (US$ Bn)

7. Global Red Biotechnology Market, By End User, 2020-2032, (US$ Bn)

8. Global Red Biotechnology Market, By Region, 2020-2032, (US$ Bn)

9. Competitive Landscape

10. Section

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界のレッドバイオテクノロジー市場- コロナウイルス（COVID-19）パンデミックの影響

第5章世界のレッドバイオテクノロジー市場、製品タイプ別、2020-2032年

第6章世界のレッドバイオテクノロジー市場、用途別、2020-2032年

第7章世界のレッドバイオテクノロジー市場、エンドユーザー別、2020-2032年

第8章世界のレッドバイオテクノロジー市場、地域別、2020年～2032年

第9章競合情勢

第10章セクション